Not applicableStudy completedNCT01138306What this trial is testingBiomarkers in Samples From Young Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 149
Early research (Phase 1)Study completedNCT01149915What this trial is testingStudy of Hypoxia-Activated Prodrug TH-302 to Treat Advanced LeukemiasWho this might be right forAcute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+3 more Threshold Pharmaceuticals 40
Not applicableEnded earlyNCT00253552What this trial is testingG-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00863148What this trial is testingAllogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)Who this might be right forMDSAMLALL+1 more Nantes University Hospital 30
Not applicableStudy completedNCT00499785What this trial is testingPhysical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forCognitive/Functional EffectsDepressionLeukemia Wake Forest University Health Sciences 11
Testing effectiveness (Phase 2)Study completedNCT00003335What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Case Comprehensive Cancer Center 44
Early research (Phase 1)Looking for participantsNCT06191978What this trial is testingA Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01253447What this trial is testingAKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)WithdrawnNCT04044209What this trial is testingThe IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDSWho this might be right forMyelodysplastic SyndromesAcute Myeloid Leukemia Yale University
Not applicableEnded earlyNCT00513318What this trial is testingPilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more University of California, San Francisco 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06858618What this trial is testingFCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid NeoplasmsWho this might be right forSafetyAntitumor ActivityPK Profile Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT00797758What this trial is testingReduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Assistance Publique - Hôpitaux de Paris 76
Testing effectiveness (Phase 2)Study completedNCT00065143What this trial is testingClofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeWho this might be right forLeukemia, MyeloidMyelodysplastic Syndromes M.D. Anderson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT00136084What this trial is testingTreatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or MyelodysplasiaWho this might be right forLeukemia, Myelocytic, Acute St. Jude Children's Research Hospital 238
Testing effectiveness (Phase 2)Ended earlyNCT01573247What this trial is testingSafety Study of AKN-028 in Patients With Acute Myelogenous LeukemiaWho this might be right forAcute Myeloid Leukemia Akinion Pharmaceuticals AB 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980885What this trial is testingA Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Akeso 68
Early research (Phase 1)Study completedNCT05470140What this trial is testingWU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Allotera Therapeutics 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT01885689What this trial is testingClofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic LeukemiaWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in Remission+4 more City of Hope Medical Center
Early research (Phase 1)Study completedNCT02485535What this trial is testingSelinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After TransplantWho this might be right forAcute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more University of Chicago 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07562568What this trial is testingSHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDSWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more The First Affiliated Hospital of Soochow University 160